Swiss National Bank
IGMS

Swiss National Bank’s IGM Biosciences IGMS Stock Holding History

Swiss National Bank’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,600
Closed -$239K – 2571
2023
Q3 		$239K Hold
28,600
– – ﹤0.01% 2597
2023
Q2 		$264K Buy
28,600
+6,600
+30% +$73.9K ﹤0.01% 2597
2023
Q1 		$302K Sell
22,000
-2,500
-10% -$51.7K ﹤0.01% 2607
2022
Q4 		$417K Buy
24,500
+1,800
+8% +$36K ﹤0.01% 2604
2022
Q3 		$516K Buy
22,700
+1,200
+6% +$24.2K ﹤0.01% 2556
2022
Q2 		$388K Buy
21,500
+3,000
+16% +$53.5K ﹤0.01% 2670
2022
Q1 		$495K Buy
18,500
+1,500
+9% +$27.9K ﹤0.01% 2607
2021
Q4 		$499K Hold
17,000
– – ﹤0.01% 2668
2021
Q3 		$1.12M Buy
17,000
+400
+2% +$30.6K ﹤0.01% 2379
2021
Q2 		$1.38M Hold
16,600
– – ﹤0.01% 2325
2021
Q1 		$1.27M Buy
16,600
+200
+1% +$18.2K ﹤0.01% 2256
2020
Q4 		$1.45M Buy
16,400
+300
+2% +$21.1K ﹤0.01% 2100
2020
Q3 		$1.19M Hold
16,100
– – ﹤0.01% 2000
2020
Q2 		$1.18M Buy
+16,100
New +$978K ﹤0.01% 2017

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Swiss National Bank's IGMS Position: Q4 2023 in Review

Swiss National Bank sold out of IGM Biosciences (IGMS) in Q4 2023, closing a stake of 28,600 shares — an estimated $239K sold.

Swiss National Bank first reported a position in IGMS in Q2 2020 and held it in 14 quarters. The position peaked at $1.45M in Q4 2020. 72 funds tracked by Wall St. Rank hold IGMS as of Q4 2023.

  • Swiss National Bank reported no remaining IGM Biosciences position as of Q4 2023 after selling out during the quarter.
  • Swiss National Bank sold 28,600 IGM Biosciences shares in Q4 2023, an estimated $239K.
  • Swiss National Bank first reported a position in IGM Biosciences in Q2 2020 and held it in 14 quarters.
  • Swiss National Bank's IGM Biosciences position peaked at $1.45M in Q4 2020.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.